Who is sponsoring NCT03623594?

NCT03623594 is sponsored by Karolinska Institutet.

What drugs are being tested in NCT03623594?

Interventions in NCT03623594: Surgical repair of the diastasis.

What condition does NCT03623594 study?

NCT03623594 studies Rectus Abdominus; Diastasis, Complicating Delivery.

Is NCT03623594 still recruiting?

NCT03623594 is currently completed. Last updated 31 March 2022.

Last reviewed 2022-03-31 · How we verify

NCT03623594

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Abdominal Trunk Function After Surgical Repair of Abdominal Rectus Muscle Diastasis

Completed NA Last updated 31 March 2022

What this trial tests

NA trial testing Surgical repair of the diastasis in Rectus Abdominus; Diastasis, Complicating Delivery in 60 participants. Completed in 31 March 2021.

Timeline

1 January 2015

Primary endpoint
31 March 2017

31 March 2021

Quick facts

Lead sponsor	Karolinska Institutet
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 January 2015
Primary completion	31 March 2017
Estimated completion	31 March 2021

Drugs / interventions tested

Surgical repair of the diastasis

Conditions studied

Rectus Abdominus; Diastasis, Complicating Delivery — all drugs for Rectus Abdominus; Diastasis, Complicating Delivery →

Sponsor

Karolinska Institutet

Who can join

Adults 18 to 55, female only, with Rectus Abdominus; Diastasis, Complicating Delivery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is insufficient evidence regarding the benefit from surgical reconstruction of post-partum abdominal rectus muscle diastasis. The purpose of this study is to evaluate the abdominal trunk function preoperatively and postoperatively in a group of women undergoing surgery for abdominal rectus muscle diastasis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Karolinska Institutet trials

Trials by the same sponsor.

NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03623594 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
Last refreshed: 31 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03623594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing